Search results
Results From The WOW.Com Content Network
Eli Lilly reported fourth quarter and full-year earnings for 2024 on Thursday.The results largely beat Wall Street estimates and sent the stock up about 2%. But the company missed on GLP-1 sales. ...
Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive developments for the pharmaceutical ...
Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. Its $720 billion market capitalization also means it's the most valuable healthcare stock in the world.
2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE: LLY).At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings ...
Eli Lilly shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations.Lilly revised its revenue guidance ...
The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of September 16, 2024. Adam Spatacco has positions in Eli Lilly ...
15 Billion Reasons to Love Eli Lilly Stock Right Now. Adam Spatacco, The Motley Fool. December 17, 2024 at 6:45 AM ... This is basically a more advanced version of the price-to-earnings (P/E) ratio.
The bad news is that $15.35 divided into Lilly's $837 share price gives the stock a staggering 54.5 current-year P/E-- which is a lot for a pharma stock. (Pandemic era darling Pfizer for example ...